Leiutis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 6.90 Cr
- Company Age 13 Year, 30 Days
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 3.07 Cr
- Revenue Growth 62.34%
- Profit Growth 2.79%
- Ebitda 200.97%
- Net Worth -1.53%
- Total Assets -5.16%
About Leiutis Pharmaceuticals
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100AP2012PTC078351
-
Company No.
078351
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Jan 2012
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc-Vijayawada
Industry
What products or services does Leiutis Pharmaceuticals Private Limited offer?
Leiutis Pharmaceuticals Private Limited offers a wide range of products and services, including Business Planning and Management, Business Consultant.
Who are the key members and board of directors at Leiutis Pharmaceuticals?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Leiutis Pharmaceuticals.
Leiutis Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 62.34% increase. The company also saw a slight improvement in profitability, with a 2.79% increase in profit. The company's net worth dipped by a decrease of 1.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Leiutis Pharmaceuticals?
In 2020, Leiutis Pharmaceuticals had a promoter holding of 48.00% and a public holding of 52.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹3.07 Cr
Charges Breakdown by Lending Institutions
- Others : 2.57 Cr
- Reliance Capital Ltd : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Apr 2018 | Others | ₹0.20 M | Satisfied |
| 04 Sep 2017 | Others | ₹0.03 M | Satisfied |
| 17 Mar 2015 | Others | ₹2.55 Cr | Satisfied |
| 27 Oct 2012 | Reliance Capital Ltd | ₹5.00 M | Satisfied |
How Many Employees Work at Leiutis Pharmaceuticals?
Leiutis Pharmaceuticals has a workforce of 67 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leiutis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leiutis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
